Paragas, Althea B.

HRN: 28-64-36  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/03/2026
CEFOTAXIME 500MG (VIAL)
03/03/2026
03/10/2026
IVT
95mg
Q8
PSNB
Checking Initial Appropriateness 
03/04/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/04/2026
03/10/2026
IV
28mg
OD
PSNB
Checking Initial Appropriateness 
03/06/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
03/06/2026
03/13/2026
IVT
95mg
Q8
PSNB
Checking Initial Appropriateness 
03/19/2026
MUPIROCIN 2%, 15G (TUBE)
03/19/2026
03/24/2026
TOPICAL
As Needed
BID
Post IV Site Swelling
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: